Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page
- Check3 days agoChange DetectedThe page revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a site change rather than any modification to the study information shown.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed. This update is a metadata version change and does not affect the study content.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; study content and details appear unchanged.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior warning about funding/status (Revision: v3.4.1) as administrative updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedThe page now includes a government funding status notice and a new revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.